A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank

By sjmartinez • February 16, 2023

Kim DH, Jensen A, Jones K, Raghavan S, Phillips LS, Hung A, Sun YV, Li G, Reaven P, Zhou H, Zhou JJ. A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank. JAMIA Open. 2023 Feb 9;6(1):ooad006. doi: 10.1093/jamiaopen/ooad006. PMID: 36789288; PMCID: PMC9912368.

Tags: diabetes, diabetes complications, disease progression, Electronic health records, General Internal Medicine, phenotyping, Publications, time-to-event

Impact of COVID-19 Pandemic on Sex and Racial Disparities in Chest Pain Presentation and Management Through the Emergency Department

Hu X, Fanous E, Jackson NJ, Daso GI, Liang I, McCullough LB, Cooper RJ, Horwich TB, Watson KE, Shah JB, Shahandeh N, Calfon Press MA.[...]

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians

Qaseem A, Obley AJ, Shamliyan T, Hicks LA, Harrod CS, Crandall CJ; Clinical Guidelines Committee of the American College of Physicians. Newer Pharmacologic Treatments in[...]

“The Patient”

Thure KA. "The Patient". JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.3082. Epub ahead of print. PMID: 38635227.